Insights on the Predictive and Presymptomatic Testing Global Market to 2027 - Featuring Mapmygenome, Myriad Genetics & Pathway Genomics Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Predictive and Presymptomatic Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

The publisher brings years of research experience to the 6th edition of this report. The 142-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Global Predictive and Presymptomatic Testing Market to Reach $7.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Predictive and Presymptomatic Testing estimated at US$4.1 Billion in the year 2020, is projected to reach a revised size of US$7.7 Billion by 2027, growing at a CAGR of 9.6% over the period 2020-2027.

The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 12.7% CAGR

The Predictive and Presymptomatic Testing market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 12.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.6% and 8.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Competitors identified in this market include, among others:

• 23andMe, Inc.
• Abbott Molecular, Inc.
• BioAxis DNA Research Centre Private Limited
• Color Genomics, Inc.
• Direct Laboratory Services LLC (DirectLabs)
• Gene by Gene Ltd.
• Genomic Diagnostics
• Mapmygenome
• Myriad Genetics, Inc.
• Pathway Genomics Corporation
• Positive Bioscience, Inc.
• Quest Diagnostics, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Global Competitor Market Shares
• Predictive and Presymptomatic Testing Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

• Total Companies Profiled: 46

For more information about this report visit https://www.researchandmarkets.com/r/f4gfph